...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: In Brief Published: 14 May 2021 CARDIOVASCULAR RISK Apabetalone in chronic kidney disease

Need to check the data.

I had recalled (erroneously? wishfully?) that even the less CKD-ridden patients did significantly better when congestive heart failure was used rather than stroke as one prong of 3-point MACE. Maybe not AS better, but better enough to reach significance.  Did I imagine that memory? 

If so, her failure to mention that would be my only issue with the portion of this that can be seen sans subscription....but still good exposure overall, i think.  ?

Share
New Message
Please login to post a reply